Marie-France Tschudin was appointed President of Advanced Accelerator Applications (AAA), a Novartis company, in 2019 and is a member of the Novartis Oncology Leadership team. She has more than 25 years of broad, multi-national experience in the pharmaceutical industry.
Prior to joining AAA, Marie-France was the Head of Region Europe for Novartis Pharmaceuticals, where she led a $7.5 billion business with more than 8,000 associates. During her two-year tenure, she also served as President of the Board for the German, UK, Spanish and Italian affiliates, and was a member of the Pharma Executive Committee.
Before this, Marie-France spent ten years at Celgene International in a variety of leadership positions with increasing responsibility. From 2014 to 2016, she was Corporate Vice President Hematology-Oncology for EMEA and from 2012 to 2014, she held the position of Regional Vice President Northern Europe. From 2010 to 2011, Marie-France was General Manager Central Europe and before that she was General Manager Central Eastern Europe. Her previous roles at Celgene included Country Manager Switzerland / Deputy General Manager smaller Western European countries, and Sales & Marketing Director Western European Region / Interim Country Manager BENELUX.
Marie-France started her career in the pharmaceutical industry as a sales representative at Janssen-Cilag Farmacêutica in Portugal and later managed business units for Essex Chemie AG in Switzerland and Schering-Plough S.A in Spain.
Marie-France is a graduate of Georgetown University, Washington D.C. and holds a Masters in Business Administration from the International Institute for Management Development (IMD), in Lausanne, Switzerland.